Efficacy and Tolerability of ABBC1 in Volunteers Receiving the Influenza or Covid-19 Vaccine

Clinical trial NCT04798677 · COMPLETED

Trial details

NCT number: NCT04798677
Sponsor: AB Biotek
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Immunity Vaccine Reaction Influenza Covid19 Cytokine Storm Immunologic Deficiency Syndromes

Start date: 2020-10-29
Primary completion: 2021-06-10
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.